| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/10/2003 | CN1441675A Compositions and methods for achieving immune suppression |
| 09/10/2003 | CN1441058A Prepn process of gene recombining salmon calcitonin |
| 09/10/2003 | CN1441057A Construction method of recombinant DNA expressing epidermal growth factor in animal's mammary gland |
| 09/10/2003 | CN1440982A Construction process of recombinant DNA expressing fibroblast growth factor (FGF) inside animal mammary gland |
| 09/10/2003 | CN1440981A New-type recombinant tissue factor inhibiting peptide and its prepn and application |
| 09/10/2003 | CN1440980A Mannosan peptide and its prepn and use |
| 09/10/2003 | CN1120847C (1-3)-beta-D-glucan-binding protein, antibody that recognizes said protein, and use of said protein and antibody |
| 09/09/2003 | US6617494 Methods for identifying transgenic plants using morphological markers |
| 09/09/2003 | US6617450 P-glycoproteins and uses thereof |
| 09/09/2003 | US6617441 Nucleic acid segment encoding a polypeptide of given amino acid sequence; lyme disease; flagellin and rRNA genes |
| 09/09/2003 | US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders |
| 09/09/2003 | US6617435 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid; |
| 09/09/2003 | US6617433 Of given amino acid sequence; can use for gene expression |
| 09/09/2003 | US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer |
| 09/09/2003 | US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 09/09/2003 | US6617430 Ataxin-2 binding proteins |
| 09/09/2003 | US6617429 Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof |
| 09/09/2003 | US6617428 Immunoglobulin M(IgM); given amino acid sequence; immunomodulators; use in blocking or inhibiting humoral immune responses in transplant patients |
| 09/09/2003 | US6617427 Capable of promoting tumor necrosis factor induced apoptosis; useful as targets for screening drugs that regulate-cell cycle progression and apoptosis; use in treating degenerative diseases and cancer |
| 09/09/2003 | US6617423 Lactam bridge between aspartic acid and orinithine; increased conformational stability; useful in treatment of osteoporosis, Paget's disease or hypercalcemia |
| 09/09/2003 | US6617422 Peptide nucleic acid monomers and oligomers |
| 09/09/2003 | US6617312 Contains a sequence motif selected from the group consisting of the motifs (Asp or Glu)-Ala-Trp-(Lys or Arg) or (Tyr or Cys)-(Glu or Asp)-(Leu or Ile)-Trp; binds to vasoactive amines such as histamine |
| 09/09/2003 | US6617307 Useful for treatment of fractures, as a filler in deficient sites of bone, for inhibition of decrease in bone substance related to osteoporosis and periodontic diseases |
| 09/09/2003 | US6617171 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect |
| 09/09/2003 | US6617158 Contacting progenitor cells ex vivo with a cytokine (transforming growth factor); use for treating anemia and other blood disorders |
| 09/09/2003 | US6617156 Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 09/09/2003 | US6617133 Heating a culture medium to inactivate proteases; adsorption using particles suspended in a fluidized bed and recovering; efficiency; lower degree of coloring |
| 09/09/2003 | US6617132 Nucleotide sequences which code polypeptide for use in treating osteoporosis, tumor metastasis, microbial infections, viral infection, sepsis, inflammation, vision defects, cachicia and muscle disorders |
| 09/09/2003 | US6617131 Nucleic acid molecule encoding the potassium channel protein, KCNQ5 |
| 09/09/2003 | US6617130 Cyanophage or cyanobacteria promoter; vectors |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/09/2003 | US6617128 Nucleotide sequences coding proteins for use in prevention of bacteria infection; for use in treatment of gonorrhea |
| 09/09/2003 | US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease |
| 09/09/2003 | US6617121 Snail, new tumoral progression marker and target protein of new antitumoral compounds |
| 09/09/2003 | US6617120 Nuclear receptor for use as tool in human therapeutics and diagnostics |
| 09/09/2003 | US6617119 Monitoring sample for preferential proteins; evaluate protein configurations, hydrolyze protein, detect enzyme resistant protein, measure amount of defect related protein in sample |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | US6617109 Contacting a biological sample from a patient with a probe of given nucleotide sequence; detecting amount of an expressed polynucleotide that hybridizes to the probe |
| 09/09/2003 | US6617103 Detecting the presence of hybridized nucleic acid; use for diagnosis and treatment of genital cancer |
| 09/09/2003 | US6617101 Lipophilic quenching of viral inactivating agents |
| 09/09/2003 | US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 09/09/2003 | CA2213731C Methods and reagents for typing hla class i genes |
| 09/09/2003 | CA2193915C Method for producing a hypoallergenic wheat flour |
| 09/09/2003 | CA2062105C Purified mite allergen |
| 09/07/2003 | WO2003074701A1 p18AβrP GENE AND p18AβrP PROTEIN, NOVEL GENE/PROTEIN (p60TRP) INTERACTING THEREWITH TO INHIBIT CELL DEATH AND CELL DEATH PROMOTER |
| 09/07/2003 | CA2432937A1 P18abrp gene and p18abrp protein, and novel gene/protein (p60trp) suppressing cell death and substances promoting cell death by interaction with the same |
| 09/05/2003 | CA2374527A1 Gene of enzyme activity to generate lachrymatory factor |
| 09/04/2003 | WO2003073107A2 Neuropeptide receptor and uses thereof |
| 09/04/2003 | WO2003073106A2 Binding of pathological forms of prion proteins |
| 09/04/2003 | WO2003073097A2 Methods for isolating ligands e.g. t cell epitopes |
| 09/04/2003 | WO2003073066A2 Reagents and methods for assaying bacillus anthracis lethal factor protease |
| 09/04/2003 | WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/04/2003 | WO2003072829A1 Nanostructures containing pna joining or functional elements |
| 09/04/2003 | WO2003072828A2 Fcgammariib polymorphisms detection in system lupus erythematosus |
| 09/04/2003 | WO2003072824A1 Markers for predicting pathological conditions in haert failure and method of using the same |
| 09/04/2003 | WO2003072808A1 Assay for activity of the actriib kinase |
| 09/04/2003 | WO2003072804A2 Nanostructures containing pilin protein |
| 09/04/2003 | WO2003072803A2 Nanostructures containing antibody assembly units |
| 09/04/2003 | WO2003072800A2 Haemophilus adherence and penetration proteins |
| 09/04/2003 | WO2003072799A2 Brother of the regulator of imprinted sites (boris) |
| 09/04/2003 | WO2003072791A2 Transgenic fodder plants with an increased leaf starch content |
| 09/04/2003 | WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 09/04/2003 | WO2003072788A1 Methods and compositions for reversibly controlling expression of target genes in cells |
| 09/04/2003 | WO2003072787A2 Method for detection of leptin receptor ligands |
| 09/04/2003 | WO2003072782A1 Echinococcus antigen, gene encoding the same and method of diagnosing human hydatidosis |
| 09/04/2003 | WO2003072781A1 Mite galectin |
| 09/04/2003 | WO2003072780A1 Novel proteins, dnas thereof and use of the same |
| 09/04/2003 | WO2003072779A1 Method of using pituitary-specific genes |
| 09/04/2003 | WO2003072775A1 Alga-origin promoter, intron and terminator |
| 09/04/2003 | WO2003072774A1 K+ transporter and use thereof |
| 09/04/2003 | WO2003072763A1 Increasing plant seed production |
| 09/04/2003 | WO2003072761A1 20 human secreted proteins |
| 09/04/2003 | WO2003072759A2 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/04/2003 | WO2003072756A2 Cloning and characterization of slc26a8 and slc26a11 anion exchangers |
| 09/04/2003 | WO2003072755A2 Transgenic zebrafish models for thrombosis |
| 09/04/2003 | WO2003072754A2 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 09/04/2003 | WO2003072753A2 Multimeric binding complexes |
| 09/04/2003 | WO2003072751A2 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 09/04/2003 | WO2003072750A2 Expression of hiv-related proteins in plants |
| 09/04/2003 | WO2003072749A2 Enkurin and uses thereof |
| 09/04/2003 | WO2003072744A2 Dna construct for inducible expression of angiogenic protein and use thereof |
| 09/04/2003 | WO2003072740A2 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | WO2003072738A2 Beta chain-associated regulator of apoptosis |
| 09/04/2003 | WO2003072732A2 Methods of making hypermutable cells using pmsr homologs |
| 09/04/2003 | WO2003072731A2 STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS |
| 09/04/2003 | WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines |
| 09/04/2003 | WO2003072723A2 Intracellular signaling molecules |
| 09/04/2003 | WO2003072722A2 IMMUNOGENIC AVIAN HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
| 09/04/2003 | WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/04/2003 | WO2003072716A2 Sequence analysis of the tetravalent rotavirus vaccine |
| 09/04/2003 | WO2003072715A2 Gasp1: a follistatin domain containing protein |
| 09/04/2003 | WO2003072714A2 Follistatin domain containing proteins |
| 09/04/2003 | WO2003072713A2 Use of bcma as an immunoregulatory agent |
| 09/04/2003 | WO2003072712A2 A novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 09/04/2003 | WO2003072710A2 Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| 09/04/2003 | WO2003072709A2 Variant tat proteins and methods for use thereof |
| 09/04/2003 | WO2003072706A2 Nucleic acid molecules encoding proteins essential for fungal growth and development and uses thereof |